Deuterated Phenanthrene Tetraol in Smokers Who Are at High Risk For Lung Cancer

Completed

Conditions studied: Lung Cancer, Squamous Lung Dysplasia, Tobacco Use Disorder

In brief

This clinical trial studies deuterated phenanthrene tetraol in smokers who are at high risk for lung cancer. Studying samples of urine in the laboratory from smokers who are at high risk for lung cancer may help doctors learn more about biomarkers related to cancer.

Key facts

Study ID

NCT01673711

Run by

University of Minnesota

People needed

350

Starts

2012-07-01

Expected to finish

2019-09-30

Last updated by the study team

2019-10-09

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

Where it is running

• Mayo Clinic — Rochester, Minnesota, United States
• Roswell Park Cancer Institute — Buffalo, New York, United States
• BC Cancer Agency — Vancouver, British Columbia, Canada

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.